3 Results for "

vactosertib tew 7197

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "vactosertib tew 7197" in MCE Product Catalog:

13
13 Cited Publications
Cat. No.: HY-19928
CAS No.: 1352608-82-2
Synonyms: EW-7197; tew-7197
Target:  

TGF-β Receptor

Domaines de recherche:  

Cancer

Vactosertib (EW-7197) is a potent, orally active and ATP-competitive activin receptor-like kinase 5 (ALK5) inhibitor with an IC50 of 12.9 nM. Vactosertib also inhibits ALK2 and ALK4 (IC50 of 17.3 nM) at nanomolar concentrations. Vactosertib has potently antimetastatic activity and anticancer effect .
loading...
    loading...
13
13 Cited Publications
Cat. No.: HY-19928A
CAS No.: 1352610-25-3
Synonyms: EW-7197 Hydrochloride; tew-7197 Hydrochloride
Target:  

TGF-β Receptor

Domaines de recherche:  

Cancer

Vactosertib Hydrochloride (EW-7197 Hydrochloride) is a potent, orally active and ATP-competitive activin receptor-like kinase 5 (ALK5) inhibitor with an IC50 of 12.9 nM. Vactosertib Hydrochloride also inhibits ALK2 and ALK4 (IC50 of 17.3 nM) at nanomolar concentrations. Vactosertib Hydrochloride has potently antimetastatic activity and anticancer effect .
loading...
    loading...
Cat. No.: HY-19928R
CAS No.: 1352608-82-2
Synonyms: EW-7197 (Standard); tew-7197 (Standard)
Domaines de recherche:  

Cancer

Vactosertib (Standard) is the analytical standard of Vactosertib (HY-19928). This product is intended for research and analytical applications. Vactosertib (EW-7197) is a potent, orally active and ATP-competitive activin receptor-like Kinase 5 (ALK5) inhibitor with an IC50 of 12.9 nM. Vactosertib also inhibits ALK2 and ALK4 (IC50 of 17.3 nM) at nanomolar concentrations. Vactosertib has potently antimetastatic activity and anticancer effect .
loading...
    loading...